Patents for C12R 1 - Micro-organisms (92,025)
01/2004
01/02/2004EP1373290A1 Pesticidal spinosyn derivatives
01/02/2004EP1373245A1 Intermediates for producing spinosyns
01/02/2004EP1372670A1 Caloporoside derivatives, methods for the production thereof and their use
01/02/2004EP0831921B1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
01/02/2004EP0506780B2 Stable integration of dna in bacterial genomes
01/01/2004US20040002533 Culture product of Streptomyces; lanosterol synthase inhibitor; anticholesterol agents, fungicides
01/01/2004US20040002458 Pharmaceutical compositions and methods using natriuretic peptides
01/01/2004US20040002144 Extrapolating the structure-binding site by replacing, inserting or deleting amino acids; x-ray crystal structure analysis; streptoverticillium mobaraense
01/01/2004US20040002142 Glucoamylase variants
01/01/2004US20040002122 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
01/01/2004US20040001904 Cellulose degrading enzymes of aspergillus
01/01/2004US20040001815 Dietary supplements for regulating male hormone
01/01/2004US20040001790 Methods for diagnosis and treatment of tumours
12/2003
12/31/2003WO2004001057A1 Process for producing carotenoids
12/31/2003WO2004001054A2 Flocculation with divalent salt
12/31/2003WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation
12/31/2003WO2004001021A1 Pasteurisation process for microbial cells and microbial oil
12/31/2003WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
12/31/2003WO2004000335A1 Lactic acid bacteria cultures that inhibit food-borne pathogens
12/31/2003WO2003000912A8 A process for the preparation of gallic acid by co-culture
12/31/2003WO2002101006A3 Production of proteins in plants
12/31/2003CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond
12/31/2003CN1132842C Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli
12/31/2003CA2489911A1 Pasteurisation process for microbial cells and microbial oil
12/30/2003US6670525 Transgenic plants and cells with altered degree of amylopectin branching
12/30/2003US6670451 Netrins
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670189 Fumonisin detoxification compositions and methods
12/30/2003US6670188 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670167 Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
12/30/2003US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors
12/30/2003US6670156 Polynucleotide encoding a diaminopimelate epimerase from Corynebacterium glutamicum
12/30/2003US6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
12/30/2003US6669969 Pesticidal use of a parasitic flagellate for eliminating or suppressing harmful algae blooms
12/30/2003US6669847 Method for water denitrification
12/30/2003CA2291931C Isochroman compounds and their production process
12/30/2003CA2163641C Multiple sclerosis virus
12/30/2003CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
12/30/2003CA2098146C Process for the preparation of 20-keto-21-alpha-hydroxy steroids and intermediates
12/25/2003US20030236390 Materials for the production of nanometer structures and use thereof
12/25/2003US20030235901 Detoxification using amylase; drug screening analysis
12/25/2003US20030235899 Catalytic domain of the human effector cell cycle checkpoint protein kinase Chk1 materials and methods for identification of inhibitors thereof
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235881 Process for the simultaneous production of xylitol and ethanol
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/24/2003WO2003106691A1 POLYPEPTIDES HAVING alpha- H-alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
12/24/2003WO2003105724A2 Novel maxi-k channel blockers, methods of use and process for making the same
12/24/2003WO2003080813A3 Lactobacillus strains
12/24/2003WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/24/2003WO2003074721A3 Method for producing riboflavin
12/24/2003WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
12/24/2003WO2003048148A9 Statin-like compounds
12/24/2003WO2003040181A3 Genes from the corynebacterium glutamicum coding for regulatory proteins
12/24/2003WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/24/2003CN1131889C Plasmid
12/24/2003CN1131663C Hypersensitive response induced resistance in plants
12/24/2003CA2488752A1 Novel maxi-k channel blockers, methods of use and process for making the same
12/23/2003US6667176 cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
12/23/2003US6667167 Storage-stable liquid formulation comprising a laccase
12/23/2003US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells.
12/23/2003US6667161 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
12/23/2003US6667066 Multi-enzyme product with glucoamylase, proteolytic and xylanase activities and method for producing same by solid state fermentation of wheat bran with Aspergillus niger
12/23/2003US6667065 Non-maltogenic exoamylases and their use in retarding retrogradation of starch
12/23/2003CA2087342C Serine protease variants having peptide ligase activity
12/18/2003WO2003104473A2 Galactosyl isomalt, method for production and use thereof
12/18/2003WO2003104472A1 Method for producing conjugated linoleic acid
12/18/2003WO2003104445A1 Aldehyde dehydrogenase
12/18/2003US20030232416 Synthesis of synthons for the manufacture of bioactive compounds
12/18/2003US20030232415 Comprises nucleotide sequences coding protein associated with avermectin biosynthesis (AVEC); antibiotic preparation; veterinary medicine
12/18/2003US20030232413 Transformed fungi for production of recombinant proteins
12/18/2003US20030232041 For use in food and feeds
12/18/2003US20030232036 Alphavirus RNA replicon systems
12/18/2003CA2490037A1 Galactosyl isomalt, a method for producing it and its use
12/18/2003CA2488060A1 Method for producing conjugated linoleic acid
12/17/2003EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
12/17/2003EP1371728A1 Gene encoding adseverin
12/17/2003EP1370677A1 Stereoselective reduction of substituted acetophenone
12/17/2003EP1370670A2 Processes for enhanced production of pantothenate
12/17/2003EP1370663A2 Microbiological method for producing l-carnitine
12/17/2003EP1370644A2 Materials and methods for the induction of premature chromosome condensation
12/17/2003EP1370643A1 Method of extracting virus from cell culture
12/17/2003EP1370578A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP0805867B1 Dna integration by transposition
12/17/2003EP0795005B1 New e.coli mutant with suppressed organic acid production
12/17/2003EP0792363B1 Novel pesticidal proteins and strains
12/17/2003EP0763101B1 Nucleic acid sequences and expression systems for heparinase iii derived from flavobacterium heparinum
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003EP0527753B2 Purification and use of pertactin, a bordetella pertussis outer membrane protein
12/17/2003EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor
12/17/2003CN1131315C Prodn. of trehalos in plant
12/17/2003CN1131313C Promoters for gene expression
12/17/2003CN1131312C N-teminally extended proteins expressed in yeast
12/17/2003CN1131240C Chromosome 21 gene marker, compositions and methods using same
12/16/2003US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders
12/16/2003US6664099 Method for the preservation of viruses and mycoplasma
12/16/2003US6664092 Nucleic acid sequences; amino acid sequences; vectors; host cells; genetic engineering; Aspergillus oryzae; use in the production of protein hydrolysates having desirable organoleptic properties and high degrees of hydrolysis
12/16/2003US6664082 Microorganism belonging to the genus Gluconobacter, which has an engineered gene for the biological activity of reducing L-sorbose which is more than 90% non- functional in developing the said biological activity.